HOLX vs. LLY
Compare and contrast key facts about Hologic, Inc. (HOLX) and Eli Lilly and Company (LLY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: HOLX or LLY.
Key characteristics
| HOLX | LLY | |
|---|---|---|
| YTD Return | 17.17% | 38.97% |
| 1Y Return | 21.92% | 42.93% |
| 3Y Return (Ann) | 6.71% | 46.71% |
| 5Y Return (Ann) | 11.55% | 50.16% |
| 10Y Return (Ann) | 12.35% | 30.96% |
| Sharpe Ratio | 1.45 | 1.34 |
| Sortino Ratio | 2.27 | 1.96 |
| Omega Ratio | 1.27 | 1.26 |
| Calmar Ratio | 1.10 | 2.12 |
| Martin Ratio | 7.67 | 7.39 |
| Ulcer Index | 3.35% | 5.40% |
| Daily Std Dev | 17.48% | 29.61% |
| Max Drawdown | -93.75% | -68.27% |
| Current Drawdown | -4.51% | -16.03% |
Fundamentals
| HOLX | LLY | |
|---|---|---|
| Market Cap | $19.45B | $777.42B |
| EPS | $2.93 | $9.11 |
| PE Ratio | 28.57 | 88.49 |
| PEG Ratio | 1.31 | 0.78 |
| Total Revenue (TTM) | $3.04B | $40.86B |
| Gross Profit (TTM) | $1.70B | $33.33B |
| EBITDA (TTM) | $851.40M | $13.78B |
Correlation
The correlation between HOLX and LLY is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
HOLX vs. LLY - Performance Comparison
In the year-to-date period, HOLX achieves a 17.17% return, which is significantly lower than LLY's 38.97% return. Over the past 10 years, HOLX has underperformed LLY with an annualized return of 12.35%, while LLY has yielded a comparatively higher 30.96% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
HOLX vs. LLY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Hologic, Inc. (HOLX) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
HOLX vs. LLY - Dividend Comparison
HOLX has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.62%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HOLX Hologic, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LLY Eli Lilly and Company | 0.62% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.94% | 2.46% | 2.77% | 2.37% | 2.84% | 3.84% |
Drawdowns
HOLX vs. LLY - Drawdown Comparison
The maximum HOLX drawdown since its inception was -93.75%, which is greater than LLY's maximum drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for HOLX and LLY. For additional features, visit the drawdowns tool.
Volatility
HOLX vs. LLY - Volatility Comparison
The current volatility for Hologic, Inc. (HOLX) is 4.30%, while Eli Lilly and Company (LLY) has a volatility of 8.29%. This indicates that HOLX experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
HOLX vs. LLY - Financials Comparison
This section allows you to compare key financial metrics between Hologic, Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities